Best in Biotech 20 Dec 2021 The Billion-Euro European Biotech Companies in 2022 …cap: €1.8B ($2B) Founded: 2012 Headquarters: Dublin, Ireland Prothena is one of the most advanced developers of passive immunotherapies for Parkinson’s disease. Passive immunotherapies use artificially designed antibodies that are… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Health Awareness Days …Day April Bowel Cancer Awareness Month IBS (irritable bowel syndrome) Awareness Month Parkinson’s Awareness Month 7 World Health Day 10 Parkinson’s Awareness Week 11 World Parkinson’s Day 13 World Sarcoidosis… November 24, 2022 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2023 NodThera announces positive inflammatory disease data …there were no serious adverse events (SAEs). Parkinson’s disease program under way by NodThera Development of NT-0796 is now progressing in a pioneering, biomarker-rich phase Ib/IIa study in Parkinson’s disease…. June 20, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jun 2022 Expansion into Europe for BlueRock Therapeutics …therapy for treating Parkinson’s disease, and intends to initiate a global non-interventional study for Parkinson’s patients in the second half of 2022. “Today’s announcement is a significant step forward in… June 10, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019 Top 10 Biotechs in Lausanne …pipeline aimed at multiple neurodegenerative diseases, the company is also developing immunotherapies for Parkinson’s and diagnostics for Alzheimer’s and progressive supranuclear palsy. Founded: 2012 Field: Cancer A decade after they… May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Opinion 25 Jul 2022 How to improve patient recruitment in your precision medicine research …patients with Parkinson’s disease because they didn’t feel comfortable explaining the meaning of test results to patients (19.6 percent) and because they were worried about the implications of the patient’s… July 25, 2022 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Apr 2023 6 biotechs that have stepped into the protein degradation space …interactions. The company acknowledges that there is a need for a novel approach to target CNS diseases such as Alzheimer’s and Parkinson’s diseases as they are caused by an accumulation… April 4, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2018 Could Stem Cells Replace Animal Testing in Drug Development? …Parkinson’s disease or a dog with diabetes as you would any product on the internet. But the ethical issues surrounding animal testing beg the question: are there equally relevant models… May 14, 2018 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
Startup Scout 10 Nov 2022 ResQ Biotech is using bacteria to discover Alzheimer’s treatments …disease, ALS, Parkinson’s disease and Huntington’s disease. Most of these conditions are difficult to treat; for example, many drugs have failed to tackle Alzheimer’s disease in clinical trials over the… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2018 International Fund Raises €300M for Dementia Research …is dedicated to investing in early-stage ventures that develop disease-modifying therapeutics for all types of dementia, including Alzheimer’s and Parkinson’s. Yesterday, the DDF completed a $350 (€300M) fundraising that far… June 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Dec 2023 Seven companies shaping the future of precision medicine …Moreover, AC Immune’s monoclonal antibody crenezumab, which also targets misfolded Abeta, is being examined in a prevention trial in Colombia. The biotech is also focused on treating Parkinson’s disease, for… December 14, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2017 Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub …managed to get its Parkinson’s drug approved earlier this year. In doing this, it became one of the first biotechs in the EU with an approved CNS drug. Xadago tackles… October 10, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email